NASDAQ : JBIO

Jade Biosciences, Inc.

$20.86 USD

$0.38 (1.86%)

Volume
653.06K
Average Volume
1.11M
Market Capitalization
$680.57M
P/E Ratio
-7.14
Dividend Yield
0.00%
Price Target
$45.00
Year High
$28.00
Year Low
$6.67
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$14.29
Insider Activity Summary (Last 12 Months)
Insiders Buying

17

Insiders Selling

0

Amount of Insider Selling

-$

JBIO Insider Buying/Selling by Quarter
JBIO Insider Trading History
Insider Name Title Date Transaction Cost Filing Date
Eisner Mark director 2026-06-25 A-Award 21.81 2026-06-26
Eisner Mark 2026-06-25 0 2026-06-26
CAIN CHRISTOPHER W. director 2026-06-09 A-Award 15.22 2026-06-11
DOBMEIER ERIC director 2026-06-09 A-Award 15.22 2026-06-11
Klein Lawrence Otto director 2026-06-09 A-Award 15.22 2026-06-11
Lavelle Erin director 2026-06-09 A-Award 15.22 2026-06-11
Fairmount Funds Management LLC director, 10 percent owner: 2026-06-09 A-Award 15.22 2026-06-11
Dahms Bradford D. officer: Chief Financial Officer 2026-02-12 A-Award 14.81 2026-02-13
Dahms Bradford D. officer: Chief Financial Officer 2026-02-12 A-Award 0 2026-02-13
Balta Elizabeth officer: See Remarks 2026-02-12 A-Award 14.81 2026-02-13
Balta Elizabeth officer: See Remarks 2026-02-12 A-Award 0 2026-02-13
Frohlich Tom director, officer: Chief Executive Officer 2026-02-12 A-Award 14.81 2026-02-13
Frohlich Tom director, officer: Chief Executive Officer 2026-02-12 A-Award 0 2026-02-13
King Andrew James officer: See Remarks 2026-02-12 A-Award 0 2026-02-13
King Andrew James officer: See Remarks 2026-02-12 A-Award 14.81 2026-02-13
Fairmount Funds Management LLC director, 10 percent owner: 2025-10-06 A-Award 9.14 2025-10-08
Fairmount Funds Management LLC director, 10 percent owner: 2025-10-06 A-Award 0.0001 2025-10-08
Dahms Bradford D. officer: Chief Financial Officer 2025-07-14 A-Award 9 2025-07-14
Dahms Bradford D. 2025-07-14 0 2025-07-14
Frohlich Tom director, officer: Chief Executive Officer 2025-05-16 P-Purchase 7.4 2025-05-19
Fairmount Funds Management LLC director, 10 percent owner: 2025-04-29 A-Award 10.14 2025-05-01
Lavelle Erin director 2025-04-29 A-Award 10.14 2025-05-01
Klein Lawrence Otto director 2025-04-29 A-Award 10.14 2025-05-01
CAIN CHRISTOPHER W. director 2025-04-29 A-Award 10.14 2025-05-01
DOBMEIER ERIC director 2025-04-29 A-Award 10.14 2025-05-01
Fairmount Funds Management LLC director, 10 percent owner: 2025-04-28 0 2025-05-01
Fairmount Funds Management LLC director, 10 percent owner: 2025-04-28 0 2025-05-01
Fairmount Funds Management LLC director, 10 percent owner: 2025-04-28 0.0001 2025-05-01
Fairmount Funds Management LLC director, 10 percent owner: 2025-04-28 0 2025-05-01
Lavelle Erin director 2025-04-28 6.03 2025-05-01
Lavelle Erin director 2025-04-28 1.53 2025-05-01
Klein Lawrence Otto director 2025-04-28 0 2025-05-01
Klein Lawrence Otto director 2025-04-28 6.03 2025-05-01
CAIN CHRISTOPHER W. 2025-04-28 0 2025-05-01
DOBMEIER ERIC director 2025-04-28 2.32 2025-05-01
DOBMEIER ERIC director 2025-04-28 6.03 2025-05-01
Balta Elizabeth officer: See Remarks 2025-04-28 2.32 2025-05-01
Balta Elizabeth officer: See Remarks 2025-04-28 6.03 2025-05-01
Kocinsky Hetal officer: Chief Medical Officer 2025-04-28 1.53 2025-05-01
Kocinsky Hetal officer: Chief Medical Officer 2025-04-28 6.03 2025-05-01
King Andrew James officer: See Remarks 2025-04-28 0 2025-05-01
King Andrew James officer: See Remarks 2025-04-28 2.32 2025-05-01
King Andrew James officer: See Remarks 2025-04-28 6.03 2025-05-01
King Andrew James officer: See Remarks 2025-04-28 0.5 2025-05-01
Quick Jonathan officer: See Remarks 2025-04-28 6.03 2025-05-01
Quick Jonathan officer: See Remarks 2025-04-28 1.53 2025-05-01
Frohlich Tom director, officer: Chief Executive Officer 2025-04-28 6.03 2025-05-01
Frohlich Tom director, officer: Chief Executive Officer 2025-04-28 1.53 2025-05-01
RA CAPITAL MANAGEMENT, L.P. 10 percent owner 2025-04-28 J-Other 0 2025-04-30